GLENMEDE TRUST CO NA - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 5.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,0000.0%2400.0%0.00%
Q2 2020$1,0000.0%2400.0%0.00%
Q1 2020$1,0000.0%2400.0%0.00%
Q4 2019$1,0002400.0%0.00%
Q3 2019$0
-100.0%
2400.0%0.00%
Q2 2019$1,000
-66.7%
2400.0%0.00%
Q1 2019$3,000
+50.0%
2400.0%0.00%
Q4 2018$2,000
-66.7%
240
-18.6%
0.00%
Q1 2018$6,0000.0%2950.0%0.00%
Q4 2017$6,000
-50.0%
2950.0%0.00%
Q3 2017$12,000
+20.0%
2950.0%0.00%
Q2 2017$10,0000.0%2950.0%0.00%
Q1 2017$10,0002950.00%
Other shareholders

There were no reported owners of FIVE PRIME THERAPEUTICS INC in Q1 2018.

NameSharesValueWeighting ↓
View complete list of FIVE PRIME THERAPEUTICS INC shareholders